Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
A website for patients with atrial fibrillation has been launched by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). The AFib Matters website, goes live today at EHRA EUROPACE 2013, which is being held 23-26 June in Athens, Greece.
Athens, 22 June 2013: Atrial fibrillation is the most common cardiac rhythm disorder, affecting 1.5-2% of the general population in the developed world (1). Over 6 million Europeans currently suffer from atrial fibrillation, and it is estimated that the prevalence will at least double in the next 50 years as the population ages (2).Patients with atrial fibrillation have a substantially increased risk of stroke. When strokes occur in patients with atrial fibrillation they are associated with more death and disability, longer hospital stays, and less chance of returning home. Atrial fibrillation is also associated with an increased risk of heart failure and impaired cognitive function including dementia.Professor Gregory YH Lip, Birmingham, UK, who was Chairman of the Task Force responsible for the development of the website, said: “Atrial fibrillation is common and is associated with increased morbidity and mortality. Patients can be extremely symptomatic and distressed, and may have a very poor quality of life.”
He added: “Patients with atrial fibrillation often have questions or misconceptions about their condition, such as whether they can travel, should they avoid certain foods, what can interact with their medication, and what is the risk of treatments. All of these questions are answered on the website.”
AFib Matters was put together by a multidisciplinary, international task force of expert clinicians and patient representatives. It outlines what atrial fibrillation is, symptoms, complications, types of drugs, and the need for stroke prevention. A section is devoted to frequently asked questions.Prof Lip said: “The website also highlights the latest developments in the treatment and management of atrial fibrillation including the new oral anticoagulant drugs, ablation and devices. It is the authoritative website on atrial fibrillation and will be updated at regular intervals with relevant and timely information.
“We know that education on atrial fibrillation helps patients understand their condition and improves management,” he concluded. “AFib Matters will boost awareness and understanding of atrial fibrillation and dispel misconceptions of this common and distressing condition.”
Scientific Programme Online
About the European Society of CardiologyThe European Society of Cardiology (ESC) represents more than 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.About the European Heart Rhythm AssociationThe European Heart Rhythm Association (EHRA) is a registered branch of the ESC. Its aim is to improve the quality of life of the European population by reducing the impact of cardiac arrhythmias and reducing sudden cardiac death.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved